Evidence map›Paper›PMID 17222866›Full record

ArticleJournal of molecular biology2007

Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity.

Michael J Volles, Peter T Lansbury

Abstract read
In one paragraph

Article in Journal of molecular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 248 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael J VollesCenter for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.
Peter T Lansbury
Brigham and Women's Hospital · US

Funding

The chemical genetics of PD: a high throughput drug screening programP50NS038375 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI STEIN, ROSS L · 1999 to 2009
$14.9M
AMYLOID DEPOSITION IN ALZHEIMERS DISEASER01AG008470 · NIA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANSBURY, PETER T · 1989 to 2005
$2.3M
Discovery of highly toxic synuclein sequence variantsR03NS051243 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI LANSBURY, PETER T · 2005 to 2006
$173k
NIA NIH HHS AG008470NIA NIH HHS R01 AG008470NIA NIH HHS R01 AG008470-17NINDS NIH HHS NS038375NINDS NIH HHS NS051243NINDS NIH HHS P50 NS038375NINDS NIH HHS P50 NS038375-07NINDS NIH HHS R03 NS051243NINDS NIH HHS R03 NS051243-02
6 · The paper itself

Abstract

To investigate the alpha-synuclein protein and its role in Parkinson's disease, we screened a library of random point mutants both in vitro and in yeast to find variants in an unbiased way that could help us understand the sequence-phenotype relationship. We developed a rapid purification method that allowed us to screen 59 synuclein mutants in vitro and discovered two double-point mutants that fibrillized slowly relative to wild-type, A30P, and A53T alpha-synucleins. The yeast toxicity of all of these proteins was measured, and we found no correlation with fibrillization rate, suggesting that fibrillization is not necessary for synuclein-induced yeast toxicity. We found that beta-synuclein was of intermediate toxicity to yeast, and gamma-synuclein was non-toxic. Co-expression of Parkinson's disease-related genes DJ-1, parkin, Pink1, UCH-L1, or synphilin, with synuclein, did not affect synuclein toxicity. A second screen, of several thousand library clones in yeast, identified 25 non-toxic alpha-synuclein sequence variants. Most of these contained a mutation to either proline or glutamic acid that caused a defect in membrane binding. We hypothesize that yeast toxicity is caused by synuclein binding directly to membranes at levels sufficient to non-specifically disrupt homeostasis.

Indexed as

alpha-SynucleinAmino Acid SequenceCell MembraneElectroporationEscherichia coliGreen Fluorescent ProteinsHumansKineticsMolecular Sequence DataMutagenesisNerve Tissue ProteinsParkinson DiseasePoint MutationProtein Structure, TertiaryRecombinant Fusion ProteinsSaccharomyces cerevisiaealpha-SynucleinGreen Fluorescent ProteinsNerve Tissue ProteinsRecombinant Fusion Proteins

Identifiers

PMID17222866
PMCPMC1868670
OpenAlexW2105488386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.